Tuesday, December 01, 2015

Sorry Shkreli Express Scripts just Did an End-Around on $750 a Pill Price Hike

That is what happens when you don't have patent exclusivity. I guess this is why "me-too" drugs come to market.

Express Scripts, one of the leading prescription-benefits managers in the US, is partnering with a compounding pharmacy to provide a $1-per-pill version of the drug that Turing Pharmaceuticals charges $750 for.

The drug, which Turing sells under the name Daraprim, is used to treat toxoplasmosis, an infection that's harmful to people with weakened immune systems.

Express Scripts announced the partnership with Imprimis Pharmaceuticals on Tuesday, and said prescriptions could be filled as soon as this week. In October, Imprimis said it would provide a customizable formulation to compete with Daraprim.


No comments: